Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Flow Cytometry01:23

Flow Cytometry

The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European Myeloma Network Group review and consensus statement on primary plasma cell leukemia.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors.

Leukemia·2024
Same author

Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.

ESMO open·2022
Same author

Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322].

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Related Experiment Video

Updated: May 29, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

Flow cytometry in monoclonal gammopathies.

L Kovárová1, T Varmuzová, P Zarbochová

  • 1Laboratory of Experimental Hematology and Cell Immunotherapy, Department of Clinical Hematology, University Hospital Brno, Czech Republic. Ikovarova@fnbrno.cz

Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|September 20, 2011
PubMed
Summary

Flow cytometry (FC) is crucial for diagnosing and understanding monoclonal gammopathy (MG). Standardizing FC methods will improve clinical insights and patient care for MG.

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

Related Experiment Videos

Last Updated: May 29, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

Area of Science:

  • Immunology
  • Hematology
  • Clinical Diagnostics

Background:

  • Technological advancements in flow cytometry (FC) highlight its importance in monoclonal gammopathy (MG) research.
  • Immunophenotyping via FC offers significant diagnostic, prognostic, and predictive value in MG.
  • Current applications and overall significance of FC in MG require further analysis.

Purpose of the Study:

  • To standardize flow cytometry (FC) methods for monoclonal gammopathy (MG) research.
  • To implement standardized FC into routine clinical examination for MG.
  • To enhance the understanding of MG pathophysiology through standardized FC analysis.

Main Methods:

  • Development and validation of standardized flow cytometry (FC) protocols.
  • Implementation of standardized FC assays in a clinical research setting.
  • Comparative analysis of data obtained through standardized vs. non-standardized FC methods.

Main Results:

  • Standardization of FC provides consistent and reliable immunophenotyping data for MG.
  • Standardized FC aids in distinguishing MG subtypes and assessing disease burden.
  • The study establishes a foundation for routine clinical application of FC in MG.

Conclusions:

  • Standardized flow cytometry (FC) is essential for accurate diagnosis and management of monoclonal gammopathy (MG).
  • Implementing standardized FC protocols will improve the clinical utility and prognostic value of immunophenotyping in MG.
  • Further research is needed to fully elucidate the role of standardized FC in MG pathophysiology.